NovoCure (N2VC34.SA) Q4 2023 Earnings

22FebConfirmed
Q4 2023
-2.59
-2.47
-2.35
-2.23

Details

Expected EPS
-2.5874226168
Actual EPS
-2.233035
Surprise EPS
0.35
Surprise Percent
+13.7%

Description

NovoCure (N2VC34.SA) has reported earnings of -2.233035 per share for Q4 2023.

0 Comments

Share your thoughts